Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ST. PETERSBURG, Russia, July 17, 2013 /PRNewswire/ --
OJSC Pharmsynthez (Leningrad region, MICEX: LIFE) (“Pharmsynthez” or “the Company”), the leading Russian biopharmaceutical company that specializes in the development, manufacture and distribution of pharmaceuticals, has today published its consolidated audited results for the full year period ending 31 December 2012, in line with US GAAP. The results were compiled by leading global auditor, Ernst & Young.
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
